Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |